Yıl: 2022 Cilt: 19 Sayı: 4 Sayfa Aralığı: 431 - 441 Metin Dili: İngilizce DOI: 10.4274/tjps.galenos.2021.83548 İndeks Tarihi: 28-09-2022

Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease

Öz:
Objectives: Coronaviruses (CoVs) cause infections that affect the respiratory tract, liver, central nervous, and the digestive systems in humans and animals. This study focused on the main protease (Mpro) in CoVs (PDB ID: 6LU7) that is used as a potential drug target to combat 2019-CoV. In this study, a total of 35 secondary metabolites from medical plants was selected and docked into the active site of 6LU7 by molecular docking studies to find a potential inhibitory compound that may be used to inhibit Coronavirus Disease-2019 (COVID-19) infection pathway. Materials and Methods: The chemical structures of the ligands were obtained from the Drug Bank (https://www.drugbank.ca/). AutoDockTools (ADT ver. 1.5.6) was used for molecular docking studies. The docking results were evaluated using BIOVIA Discovery Studio Visualizer and PyMOL (ver. 2.3.3, Schrodinger, LLC). Results: Pycnamine, tetrahydrocannabinol, oleuropein, quercetin, primulic acid, kaempferol, dicannabidiol, lobelin, colchicine, piperidine, medicagenic acid, and narcotine is found to be potential inhibitors of the COVID-19 Mpro. Among these compounds, pycnamine, which was evaluated against COVID-19 for the first time, showed a high affinity to the COVID-19 Mpro compared with other seconder metabolites and reference drugs. Conclusion: Our results obtained from docking studies suggest that pycnamine should be examined in vitro to combat 2019-CoV. Moreover, pycnamine might be a promising lead compound for anti-CoV drugs.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprint. doi: 10.20944/preprints202003.0226.v1.
  • 2. Bolelli K, Ertan-Bolelli T, Unsalan O, Altunayar-Unsalan C. Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: a virtual screening study. J Mol Struct. 2021;1228:129449.
  • 3. WHO. COVID-19 Weekly Epidemiological Update Report. World Health Organization; 11 May 2021. p. 1-2.
  • 4. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14:64-68. Erratum in: Biosci Trends. 2020;14:E1.
  • 5. Xu Z, Peng C, Shi Y, Zhu Z, Mu K, Wang X, Zhu W. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv. 2020. doi: https://doi. org/10.1101/2020.01.27.921627.
  • 6. Chang YC, Tung YA, Lee KH, Chen TF, Hsiao YC, Chang HC, Hsieh TT, Su CH, Wang SS, Yu JY, Shih SS, Lin YH, Lin YH, Tu YCE, Chen CY. Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. Preprint. 2020. doi: 10.20944/ preprints202002.0242.v2
  • 7. Durdagi S, Orhan MD, Aksoydan B, Calis S, Dogan B, Sahin K, Shahraki A, Iyison NB, Avsar T. Screening of clinically approved and investigation drugs as potential inhibitors of SARS-CoV-2: a combined in silico and in vitro study. Mol Inform. 2022;41:e2100062.
  • 8. Orhan IE, Senol Deniz FS. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Nat Prod Bioprospect. 2020;10:171-186.
  • 9. Kumar S, Maurya VK, Kabir R, Nayak D, Khurana A, Manchanda RK, Gadugu S, Shanker K, Saxena SK. Antiviral activity of belladonna during Japanese encephalitis virus infection via inhibition of microglia activation and inflammation leading to neuronal cell survival. ACS Chem Neurosci. 2020;11:3683-3696.
  • 10. Yang CW, Lee YZ, Kang IJ, Barnard DL, Jan JT, Lin D, Huang CW, Yeh TK, Chao YS, Lee SJ. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Antiviral Res. 2010;88:160-168.
  • 11. Kang KB, Ming G, Kim GJ, Ha TK, Choi H, Oh WK, Sung SH. Jubanines F-J, cyclopeptide alkaloids from the roots of Ziziphus jujuba. Phytochemistry. 2015;119:90-95.
  • 12. Wu W, Li R, Li X, He J, Jiang S, Liu S, Yang J. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses. 2015;8:6.
  • 13. Behbahani M, Sayedipour S, Pourazar A, Shanehsazzadeh M. In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca. Res Pharm Sci. 2014;9:463-469.
  • 14. Fredrickson WR. Method and composition for antiviral therapy. Google Patents; 2000.
  • 15. Lai WL, Chuang HS, Lee MH, Wei CL, Lin CF, Tsai YC. Inhibition of Herpes simplex virus type 1 by thymol-related monoterpenoids. Planta Med. 2012;78:1636-1638.
  • 16. Ma SC, He ZD, Deng XL, But PP, Ooi VE, Xu HX, Lee SH, Lee SF. In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. Chem Pharm Bull (Tokyo). 2001;49:1471-1473.
  • 17. Astani A, Reichling J, Schnitzler P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother Res. 2010;24:673-679.
  • 18. Bermejo P, Abad MJ, Díaz AM, Fernández L, De Santos J, Sanchez S, Villaescusa L, Carrasco L, Irurzun A. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med. 2002;68:106-110.
  • 19. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008;47:804-811.
  • 20. Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med. 2006;72:1169-1174.
  • 21. De Tommasi N, Conti C, Stein ML, Pizza C. Structure and in vitro antiviral activity of triterpenoid saponins from Calendula arvensis. Planta Med. 1991;57:250-253.
  • 22. Pecetti L, Biazzi E, Tava A. Variation in saponin content during the growing season of spotted medic [Medicago arabica (L.) Huds.]. J Sci Food Agric. 2010;90:2405-2410.
  • 23. Oso BJ, Adeoye AO, Olaoye IF. Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases. J Biomol Struct Dyn. 2022;40:389-400.
  • 24. Patwardhan M, Morgan MT, Dia V, D’Souza DH. Heat sensitization of hepatitis A virus and Tulane virus using grape seed extract, gingerol and curcumin. Food Microbiol. 2020;90:103461.
  • 25. Bilginer S, Gul HI, Anil B, Demir Y, Gulcin I. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors. Arch Pharm (Weinheim). 2021;354:e2000243.
  • 26. Samant L, Javle V. Comparative docking analysis of rational drugs against COVID-19 main protease. Biological Med. Chem 2020.
  • 27. Hatada R, Okuwaki K, Mochizuki Y, Handa Y, Fukuzawa K, Komeiji Y, Okiyama Y, Tanaka S. Fragment molecular orbital based interaction analyses on COVID-19 main protease - inhibitor N3 complex (PDB ID: 6LU7). J Chem Inf Model. 2020;60:3593-3602.
  • 28. Li JY, You Z, Wang Q, Zhou ZJ, Qiu Y, Luo R, Ge XY. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22:80- 85.
  • 29. Yamamoto N, Yang R, Yoshinaka Y, Amari S, Nakano T, Cinatl J, Rabenau H, Doerr HW, Hunsmann G, Otaka A, Tamamura H, Fujii N, Yamamoto N. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun. 2004;318:719-725.
  • 30. Spiff AI, Zabel V, Watson WH, Zemaitis MA, Ateya AM, Slatkin DJ, Knapp JE, Schiff PL Jr. Constituents of West African medicinal plants. XXX. Tridictyophylline, a new morphinan alkaloid from Triclisia dictyophylla. J Nat Prod. 1981;44:160-165.
  • 31. Valentin A, Benoit-Vical F, Moulis C, Stanislas E, Mallié M, Fouraste I, Bastide JM. In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides. Antimicrob Agents Chemother. 1997;41:2305-2307.
  • 32. Hernandez E, Santos A. Alkaloid of Pycnarrhena manillensis vidal. (family Menispermaceae). Constitution of Pycnamine. (Thesis) University of the Philippines. 28 pp., 1935. Jour. Philippine Pharm. 1946.
  • 33. Gupta NC, Bhakuni DS, Dhar MM. Pendulin, a new biscoclaurine alkaloid from Cocculus pendulus Diels. Experientia. 1970;26:12-13.
  • 34. Lin M. Part I. Isolation and identification of quaternary alkaloids from the roots of Thalictrum cultratum Wall. (Ranunculaceae). Part II. Isolation and identification of alkaloids from the roots and stems of Pycnarrhena manillensis Vidal (Menispermaceae) (1st ed). St. Petersburg; 1989:79-85.
  • 35. Ragasa CY, Tepora MM, Rideout J. Antimicrobial activities of sterol from Pycnarrhena manillensis. ACGC Chemical Res Comm. 2009;23:31-34.
  • 36. Simanjuntak P. Tumbuhan sebagai sumber zat aktif antimalaria. Repositori Riset Kesehatan Nasional. 2019;46:125-132.
  • 37. Marshall SJ, Russell PF, Wright CW, Anderson MM, Phillipson JD, Kirby GC, Warhurst DC, Schiff PL Jr. In vitro antiplasmodial, antiamoebic, and cytotoxic activities of a series of bisbenzylisoquinoline alkaloids. Antimicrob Agents Chemother. 1994;38:96-103.
  • 38. Sharma P, Sharma JD. A review of plant species assessed in vitro for antiamoebic activity or both antiamoebic and antiplasmodial properties. Phytother Res. 2001;15:1-17.
  • 39. Kodi P. Antiplasmodial and toxicity activities and characterization of chemical compounds extracted from selected medicinal plants in Uganda (1st ed). Njero; Egerton University, 2018:87-95.
  • 40. Cabral GA, Vasquez R. Delta 9-tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity. Proc Soc Exp Biol Med. 1992;199:255-263.
  • 41. Nediani C, Ruzzolini J, Romani A, Calorini L. Oleuropein, a bioactive compound from Olea europaea L., as a potential preventive and therapeutic agent in non-communicable diseases. Antioxidants (Basel). 2019;8:578.
  • 42. Barbaro B, Toietta G, Maggio R, Arciello M, Tarocchi M, Galli A, Balsano C. Effects of the olive-derived polyphenol oleuropein on human health. Int J Mol Sci. 2014;15:18508-18524.
  • 43. Karaboğa Arslan AK, Öztürk E, Yerer MB, Koşar M. Oleuropein in olive leaf and its pharmacologial effects. J Health Sci. 2017;26:89-93.
  • 44. Micol V, Caturla N, Pérez-Fons L, Más V, Pérez L, Estepa A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res. 2005;66:129-136.
  • 45. Omar SH. Oleuropein in olive and its pharmacological effects. Sci Pharm. 2010;78:133-154.
  • 46. Zhao G, Yin Z, Dong J. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum. J Ethnopharmacol. 2009;125:265-268.
  • 47. Bureau S, Ruiz D, Reich M, Gouble B, Bertrand D, Audergon JM, Renard CMGC. Rapid and non-destructive analysis of apricot fruit quality using FT-near-infrared spectroscopy. Food Chem. 2009;113:1323-1328.
  • 48. Liu M, Yu Q, Xiao H, Li M, Huang Y, Zhang Q, Li P. The inhibitory activities and antiviral mechanism of medicinal plant ingredient quercetin against grouper iridovirus infection. Front Microbiol. 2020;11:586331.
  • 49. Lyu SY, Rhim JY, Park WB. Antiherpetic activities of flavonoids against Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res. 2005;28:1293-1301.
  • 50. Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections. Arch Virol. 2017;162:2539-2551.
  • 51. Debiaggi M, Tateo F, Pagani L, Luini M, Romero E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica. 1990;13:207-213.
  • 52. De Palma AM, Vliegen I, De Clercq E, Neyts J. Selective inhibitors of picornavirus replication. Med Res Rev. 2008;28:823-884.
  • 53. Agrawal PK, Agrawal C, Blunden G. Quercetin: antiviral significance and possible COVID-19 integrative considerations. Nat Prod Commun. 2020;15:1-10.
  • 54. Ganesan S, Faris AN, Comstock AT, Wang Q, Nanua S, Hershenson MB, Sajjan US. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antiviral Res. 2012;94:258-271.
  • 55. Hossen MJ, Uddin MB, Ahmed SSU, Yu Z-L, Cho JY. Kaempferol: review on natural sources and bioavailability. Kaempferol: Biosynthesis, Food Sources and Therapeutic Uses; Nova Science Publishers: New York, NY, USA. 2016:101-150.
  • 56. Jeong HJ, Ryu YB, Park SJ, Kim JH, Kwon HJ, Kim JH, Park KH, Rho MC, Lee WS. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem. 2009;17:6816-6823.
  • 57. Zhang W, Qiao H, Lv Y, Wang J, Chen X, Hou Y, Tan R, Li E. Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS One. 2014;9:e110429.
  • 58. Helal R, Melzig MF. In vitro effects of selected saponins on the production and release of lysozyme activity of human monocytic and epithelial cell lines. Sci Pharm. 2011;79:337-349.
  • 59. Czarnecki R, Librowski T. The effect of primulic acid on experimental, chronic venous insufficiency. Eur J Pharm Sci. 1996:121.
  • 60. Grecu L, Cucu V. Saponine aus Primula officinalis and Primula elatior. Planta Med. 1975;27:247-253.
  • 61. Morozowska M. Vegetative development, flowering, fruiting and saponin content in cultivated cowslip [Primula veris L.] plants. Herba Pol. 2004:2.
  • 62. El-Tantawy WH, Temraz A, Hozaien HE, El-Gindi OD, Taha KF. Anti hyperlipidemic activity of an extract from roots and rhizomes of Panicum repens L. on high cholesterol diet-induced hyperlipidemia in rats. Z Naturforsch C J Biosci. 2015;70:139-144.
  • 63. Martinenghi LD, Jønsson R, Lund T, Jenssen H. Isolation, purification, and antimicrobial characterization of cannabidiolic acid and cannabidiol from Cannabis sativa L. Biomolecules. 2020;10:900.
  • 64. Adams R, Pease DC, Clark JH. Isolation of cannabinol, cannabidiol and quebrachitol from red oil of Minnesota wild hemp. J Am Chem Soc. 1940;62:2194-2196.
  • 65. Lowe HI, Toyang NJ, McLaughlin W. Potential of cannabidiol for the treatment of viral hepatitis. Pharmacognosy Res. 2017;9:116-118.
APA Bilginer S, GÖZCÜ S, Güvenalp Z (2022). Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. , 431 - 441. 10.4274/tjps.galenos.2021.83548
Chicago Bilginer Sinan,GÖZCÜ SEFA,Güvenalp Zühal Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. (2022): 431 - 441. 10.4274/tjps.galenos.2021.83548
MLA Bilginer Sinan,GÖZCÜ SEFA,Güvenalp Zühal Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. , 2022, ss.431 - 441. 10.4274/tjps.galenos.2021.83548
AMA Bilginer S,GÖZCÜ S,Güvenalp Z Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. . 2022; 431 - 441. 10.4274/tjps.galenos.2021.83548
Vancouver Bilginer S,GÖZCÜ S,Güvenalp Z Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. . 2022; 431 - 441. 10.4274/tjps.galenos.2021.83548
IEEE Bilginer S,GÖZCÜ S,Güvenalp Z "Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease." , ss.431 - 441, 2022. 10.4274/tjps.galenos.2021.83548
ISNAD Bilginer, Sinan vd. "Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease". (2022), 431-441. https://doi.org/10.4274/tjps.galenos.2021.83548
APA Bilginer S, GÖZCÜ S, Güvenalp Z (2022). Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. Turkish Journal of Pharmaceutical Sciences, 19(4), 431 - 441. 10.4274/tjps.galenos.2021.83548
Chicago Bilginer Sinan,GÖZCÜ SEFA,Güvenalp Zühal Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. Turkish Journal of Pharmaceutical Sciences 19, no.4 (2022): 431 - 441. 10.4274/tjps.galenos.2021.83548
MLA Bilginer Sinan,GÖZCÜ SEFA,Güvenalp Zühal Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. Turkish Journal of Pharmaceutical Sciences, vol.19, no.4, 2022, ss.431 - 441. 10.4274/tjps.galenos.2021.83548
AMA Bilginer S,GÖZCÜ S,Güvenalp Z Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. Turkish Journal of Pharmaceutical Sciences. 2022; 19(4): 431 - 441. 10.4274/tjps.galenos.2021.83548
Vancouver Bilginer S,GÖZCÜ S,Güvenalp Z Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. Turkish Journal of Pharmaceutical Sciences. 2022; 19(4): 431 - 441. 10.4274/tjps.galenos.2021.83548
IEEE Bilginer S,GÖZCÜ S,Güvenalp Z "Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease." Turkish Journal of Pharmaceutical Sciences, 19, ss.431 - 441, 2022. 10.4274/tjps.galenos.2021.83548
ISNAD Bilginer, Sinan vd. "Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease". Turkish Journal of Pharmaceutical Sciences 19/4 (2022), 431-441. https://doi.org/10.4274/tjps.galenos.2021.83548